Professor Adrian Harris

Targeting cancer’s blood supply

Tumours need to develop their own blood supply in order to keep growing. Professor Adrian Harris' research group based at the Weatherall Institute for Molecular Medicine is studying this process of new blood vessel growth, called angiogenesis, in great detail.

Using this knowledge, they are developing ways to block angiogenesis and starve cancer cells of essential nutrients and oxygen. Professor Harris is a leading researcher in this field and is also running clinical trials to study new anti-angiogenesis drugs in people with cancer.

Cancer biology
Clinical trials

Weatherall Institute of Molecular Medicine, University of Oxford, Oxford

adrian.harris@oncology.ox.ac.uk 

Website